Alexandria Real Estate Equities (ARE-N) Stock Predictions - Stockchase
WATCH LIST
4
Alexandria Real Estate Equities (ARE-N)

ON STOCKCHASE SINCE Aug 2018

REAL ESTATE

Alexandria Real Estate Eq...

ARE-N

2 watching          
Join the Discussion

Alexandria Real Estate Equities (ARE-N) SAVE Apr, 18, 2019, 11:01 am

137.43 1.03 (0.76%)

About Alexandria Real Estate Equities (ARE-N)

Alexandria Real Estate Equities is a major United States real estate investment trust. More at Wikipedia

What the experts are saying about ARE-N



  • All
  • Filtered
Signal Opinion Expert
PAST TOP PICK
(A Top Pick Dec 05/18, Up 16%) They are a stellar company with a stellar management team. They are the dominant player of campuses to life sciences companies. It is important for these companies to be together to share ideas in an ecosystem. They have a free cash flow growth of north of 10%. He sees the company growing with their valuation. It is still a compelling investment opportunity.
REAL ESTATE
0 0 0 0 0
0 comments
(A Top Pick Dec 05/18, Up 16%) They are a stellar company with a stellar management team. They are the dominant player of campuses to life sciences companies. It is important for these companies to be together to share ideas in an ecosystem. They have a free cash flow growth of north of 10%. He sees the company growing with their valuation. It is still a compelling investment opportunity.
REAL ESTATE
0 0 0 0 0
0 comments
Joshua Varghese

Portfolio , Signature Global Ass...

Price Price
$141.540
Owned Owned
Yes

TOP PICK
The entry point is great right now. They look to double their revenues by 2022 from $900 million today. They have a great balance sheet and management team. They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more. Yield 3%. (Analysts’ price target is $138.25)
REAL ESTATE
0 0 0 0 0
0 comments
The entry point is great right now. They look to double their revenues by 2022 from $900 million today. They have a great balance sheet and management team. They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more. Yield 3%. (Analysts’ price target is $138.25)
REAL ESTATE
0 0 0 0 0
0 comments
Joshua Varghese

Portfolio , Signature Global Ass...

Price Price
$0.000
Owned Owned
Yes

PAST TOP PICK
(A Top Pick Aug 16/18, Down 3%) They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more.
REAL ESTATE
0 0 0 0 0
0 comments
(A Top Pick Aug 16/18, Down 3%) They hold assets in all the major US campuses. They are the curators of new biotech and big pharma real estate start-ups on and near these campuses. When a lease comes due, they can raise rents 30% or more.
REAL ESTATE
0 0 0 0 0
0 comments
Joshua Varghese

Portfolio , Signature Global Ass...

Price Price
$0.000
Owned Owned
Yes

TOP PICK

They specialize in technology and life-sciences clusters. Their tenants will be repatriation cash, so ARE's partnership with these tenants will create value and rent growth. (2.9% dividend yield)

REAL ESTATE
0 0 0 0 0
0 comments

They specialize in technology and life-sciences clusters. Their tenants will be repatriation cash, so ARE's partnership with these tenants will create value and rent growth. (2.9% dividend yield)

REAL ESTATE
0 0 0 0 0
0 comments
Joshua Varghese

Portfolio , Signature Global Ass...

Price Price
$128.620
Owned Owned
Yes

Showing 1 to 4 of 4 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days